Literature DB >> 23153997

Functional magnetic resonance imaging of methamphetamine craving.

Jing-Jing Yin1, Shu-Hua Ma, Ke Xu, Zhao-Xin Wang, Hong-Bo Le, Jin-Zhuang Huang, Ke-Ming Fang, Ling-Min Liao, Ze-Long Cai.   

Abstract

The study aimed to explore the abnormal activation of special brain areas associated with methamphetamine craving using functional magnetic resonance imaging (fMRI) and to reveal the neurobiological basis of addiction. Twenty-six methamphetamine addicts and 26 healthy subjects were scanned by brain fMRI while watching pictures of happy, sad, or methamphetamine to acquire resource data. SPM5 was used to analyze fMRI data to get related brain activation map, and it was found that methamphetamine addicts had high brain activation in cingulate and low activation in frontal lobe when watching methamphetamine-cue pictures. This study demonstrated that methamphetamine addicts had emotion-related brain activation abnormalities.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23153997     DOI: 10.1016/j.clinimag.2012.02.006

Source DB:  PubMed          Journal:  Clin Imaging        ISSN: 0899-7071            Impact factor:   1.605


  12 in total

1.  Anterior Insular Cortex is Critical for the Propensity to Relapse Following Punishment-Imposed Abstinence of Alcohol Seeking.

Authors:  Erin J Campbell; Jeremy P M Flanagan; Leigh C Walker; Mitchell K R I Hill; Nathan J Marchant; Andrew J Lawrence
Journal:  J Neurosci       Date:  2018-12-03       Impact factor: 6.167

2.  Methamphetamine affects cell proliferation in the medial prefrontal cortex: a new niche for toxicity.

Authors:  Airee Kim; Chitra D Mandyam
Journal:  Pharmacol Biochem Behav       Date:  2014-09-28       Impact factor: 3.533

3.  Methamphetamine enhances the development of schizophrenia in first-degree relatives of patients with schizophrenia.

Authors:  Huabing Li; Qiong Lu; Enhua Xiao; Qiuyun Li; Zhong He; Xilong Mei
Journal:  Can J Psychiatry       Date:  2014-02       Impact factor: 4.356

4.  The Anterior Insular Cortex→Central Amygdala Glutamatergic Pathway Is Critical to Relapse after Contingency Management.

Authors:  Marco Venniro; Daniele Caprioli; Michelle Zhang; Leslie R Whitaker; Shiliang Zhang; Brandon L Warren; Carlo Cifani; Nathan J Marchant; Ofer Yizhar; Jennifer M Bossert; Cristiano Chiamulera; Marisela Morales; Yavin Shaham
Journal:  Neuron       Date:  2017-10-11       Impact factor: 17.173

5.  Brain damages in ketamine addicts as revealed by magnetic resonance imaging.

Authors:  Chunmei Wang; Dong Zheng; Jie Xu; Waiping Lam; D T Yew
Journal:  Front Neuroanat       Date:  2013-07-17       Impact factor: 3.856

6.  Psychopathic traits modulate brain responses to drug cues in incarcerated offenders.

Authors:  Lora M Cope; Gina M Vincent; Justin L Jobelius; Prashanth K Nyalakanti; Vince D Calhoun; Kent A Kiehl
Journal:  Front Hum Neurosci       Date:  2014-02-24       Impact factor: 3.169

7.  Parallel changes in serum proteins and diffusion tensor imaging in methamphetamine-associated psychosis.

Authors:  Michael S Breen; Anne Uhlmann; Sureyya Ozcan; Man Chan; Dalila Pinto; Sabine Bahn; Dan J Stein
Journal:  Sci Rep       Date:  2017-03-02       Impact factor: 4.379

Review 8.  Dark Times: The Role of Negative Reinforcement in Methamphetamine Addiction.

Authors:  April C May; Robin L Aupperle; Jennifer L Stewart
Journal:  Front Psychiatry       Date:  2020-03-17       Impact factor: 4.157

9.  Comparison of brain white matter hyperintensities in methamphetamine and methadone dependent patients and healthy controls.

Authors:  Abdulrasool Alaee; Mehran Zarghami; Samaneh Farnia; Mohammad Khademloo; Talayeh Khoddad
Journal:  Iran J Radiol       Date:  2014-05-15       Impact factor: 0.212

10.  Craving Responses to Methamphetamine and Sexual Visual Cues in Individuals With Methamphetamine Use Disorder After Long-Term Drug Rehabilitation.

Authors:  Shucai Huang; Zhixue Zhang; Yuanyuan Dai; Changcun Zhang; Cheng Yang; Lidan Fan; Jun Liu; Wei Hao; Hongxian Chen
Journal:  Front Psychiatry       Date:  2018-04-19       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.